Commonwealth Bank of Australia’s Ionis Pharmaceuticals IONS Stock Holding History

Commonwealth Bank of Australia’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-600	Closed	-$22K	–	866
2016 Q3	$22K	Hold	600	–	–	﹤0.01%	817
2016 Q2	$14K	Hold	600	–	–	﹤0.01%	792
2016 Q1	$24K	Buy	600 +300	+100%	+$12.2K	﹤0.01%	789
2015 Q4	$19K	Hold	300	–	–	﹤0.01%	815
2015 Q3	$12K	Buy	+300	New	+$15.5K	﹤0.01%	835

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Bank of Australia's IONS Position: Q4 2016 in Review

Commonwealth Bank of Australia sold out of Ionis Pharmaceuticals (IONS) in Q4 2016, closing a stake of 600 shares — an estimated $22K sold.

Commonwealth Bank of Australia first reported a position in IONS in Q3 2015 and held it in 5 quarters. The position peaked at $24K in Q1 2016. 309 funds tracked by Wall St. Rank hold IONS as of Q4 2016.

Commonwealth Bank of Australia reported no remaining Ionis Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Commonwealth Bank of Australia sold 600 Ionis Pharmaceuticals shares in Q4 2016, an estimated $22K.
Commonwealth Bank of Australia first reported a position in Ionis Pharmaceuticals in Q3 2015 and held it in 5 quarters.
Commonwealth Bank of Australia's Ionis Pharmaceuticals position peaked at $24K in Q1 2016.
309 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2016.

Based on Commonwealth Bank of Australia's 13F filing for Q4 2016, filed 14 Feb 2017.